BioMérieux

The BioFire FilmArray Pneumonia panel will be used to optimize clinical trial enrollment for an antibiotic to treat combat carbapenem-resistant A. baumannii infections.

GenMark got clearance for an assay to detect fungal pathogens from blood cultures of patients with suspected bloodstream infections, and it received clearance for a bacterial assay.

Despite a recent positive economic modeling study, the debate over appropriate use of the ME panel seems likely to continue until more outcomes studies are conducted.

The year saw the launch of high-profile platforms as well as efforts by a number of parties to streamline mass spec technologies for the clinic.

The test is the second of three panels intended to detect pathogens that cause the bloodstream infections that can lead to sepsis.

During the year, the growing threat of antimicrobial resistance drove development and adoption of advanced diagnostic tests, including molecular testing.

The bottles support growth of aerobic and anaerobic organisms for quality control testing of platelets. 

The BioFire FilmArray Pneumonia Panel was cleared by the FDA while the BioFire FilmArray Pneumonia Panel Plus was CE marked.

BioMérieux had previously acquired a minority stake in Hybiome, which specializes in automated immunoassays, in July.

The company's third quarter revenue increase was driven in part by strong growth in its molecular biology clinical applications.

Pages